These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 27777386)
21. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy. Obach RS Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671 [TBL] [Abstract][Full Text] [Related]
22. Role of pharmacologically active metabolites in drug discovery and development. Fura A Drug Discov Today; 2006 Feb; 11(3-4):133-42. PubMed ID: 16533711 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of gastrointestinal motility directly from human pharmacokinetic data. Roush JA Int J Pharm; 2011 Oct; 419(1-2):43-51. PubMed ID: 21784142 [TBL] [Abstract][Full Text] [Related]
24. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation. De Buck SS; Mackie CE Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030 [TBL] [Abstract][Full Text] [Related]
25. Regional intestinal drug permeation: biopharmaceutics and drug development. Lennernäs H Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845 [TBL] [Abstract][Full Text] [Related]
26. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development. Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723 [TBL] [Abstract][Full Text] [Related]
28. Pharmacometrics in pregnancy: An unmet need. Ke AB; Rostami-Hodjegan A; Zhao P; Unadkat JD Annu Rev Pharmacol Toxicol; 2014; 54():53-69. PubMed ID: 24392692 [TBL] [Abstract][Full Text] [Related]
29. Variations of pharmacokinetics of drugs in patients with cirrhosis. Pena MA; Horga JF; Zapater P Expert Rev Clin Pharmacol; 2016; 9(3):441-58. PubMed ID: 26696448 [TBL] [Abstract][Full Text] [Related]
30. Use of radioactive compounds and autoradiography to determine drug tissue distribution. Solon EG Chem Res Toxicol; 2012 Mar; 25(3):543-55. PubMed ID: 22280496 [TBL] [Abstract][Full Text] [Related]
32. Impact of Roux-en-Y Gastric Bypass Surgery on Pharmacokinetics of Administered Drugs: Implications and Perspectives. Srinivas NR Am J Ther; 2016; 23(6):e1826-e1838. PubMed ID: 26398718 [TBL] [Abstract][Full Text] [Related]
33. [Quantitative evaluation of pharmacological effects and adverse effects based on receptor occupancy theory]. Sawada Y; Yamada Y; Iga T Yakugaku Zasshi; 1997 Feb; 117(2):65-90. PubMed ID: 9084225 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis. Velenosi TJ; Urquhart BL Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1131-43. PubMed ID: 24961255 [TBL] [Abstract][Full Text] [Related]
35. Computational prediction of oral drug absorption based on absorption rate constants in humans. Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110 [TBL] [Abstract][Full Text] [Related]
36. Impact of physiologically based pharmacokinetic modeling and simulation in drug development. Shardlow CE; Generaux GT; Patel AH; Tai G; Tran T; Bloomer JC Drug Metab Dispos; 2013 Dec; 41(12):1994-2003. PubMed ID: 24009310 [TBL] [Abstract][Full Text] [Related]